Skip Navigation


All members of the Neuromuscular Program are actively involved in clinical and/or basic science research. Clinical trials of novel therapeutic agents are frequently available to interested patients. Specific research interests include investigations of the pathophysiology and treatment of:

  • amyotrophic lateral sclerosis (ALS)
  • diabetic neuropathy
  • disorders of neuromuscular transmission
  • inflammatory myopathies
  • inflammatory neuropathy
  • metabolic myopathies
  • neuropathic pain
  • neuromuscular complications of critical illness

Funding sources include the National Institutes of Health, several disease-related foundations, and many other national and local sources. Much of the research in the Neuromuscular Program is performed in conjunction with the Program for Understanding Neurologic Diseases.